Investing To Meet The Scientific Challenges Of HIV/AIDS

被引：17

作者：

Fauci, Anthony S. ^{[1
]}

Folkers, Gregory K. ^{[2
]}

机构：

[1] NIAID, NIH, Bethesda, MD 20892 USA

[2] NIAID, Immediate Off Director, Bethesda, MD 20892 USA

来源：

HEALTH AFFAIRS | 2009年 / 28卷 / 06期

关键词：

ANTIRETROVIRAL THERAPY; EXTENDED PERIODS; HIV PREVENTION; UNITED-STATES; TRANSMISSION; ERADICATION; INFECTION; RESERVOIR; VACCINE; VIRUS;

D O I：

10.1377/hlthaff.28.6.1629

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Despite extraordinary scientific advances over more than twenty-five years, the human immunodeficiency virus (HIV) continues to exact an enormous toll worldwide. Given the limitations of current HIV treatment and prevention interventions and the financial and logistical impediments to delivering them, new and potentially transforming interventions are needed if the HIV/AIDS pandemic is to be significantly slowed. Serious scientific challenges remain in the realm of developing potentially curative therapies and a safe and effective HIV vaccine, and in developing, assessing, and validating other new prevention modalities. Substantial funding of the research enterprise must be maintained. [Health Aff (Millwood). 2009;28(6):1629-41]

引用

页码：1629 / 1641

页数：13

共 29 条

[1]

*AIDS VACC ADV COA, 2009, PIEC HIV PREV PUZZL

[2]

[Anonymous], 2009, HIV/AIDS Surveillance Report, 2007, P19

[3] Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis [J].